A Phase II/III multicenter randomized single blind non-inferiority immunogenicity and safety study of TeddyVac™ vaccine of Human Biologicals Institute in healthy subjects of 10 years to 60 years of age.
| Autor: | Susarla, Sai Krishna1 (AUTHOR) s.saikrishna@indimmune.com, Narang, Manish2 (AUTHOR), Khandgave, Prashant Namdev3 (AUTHOR), Patnaik, Lipilekha4 (AUTHOR), Rajapantula, Vasudev5 (AUTHOR), M, Satish1 (AUTHOR), BC, Rajashakar1 (AUTHOR), Sahoo, Devi Prasad1 (AUTHOR), Kanakasapapathy, Anand Kumar1 (AUTHOR) |
|---|---|
| Zdroj: | Infectious Diseases. Oct2024, p1-15. 15p. 6 Illustrations. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|